Femasys raises $12M via senior secured convertible notes and warrants

FEMASYS INC

Senior secured convertible notes: $12M aggregate principal, 8.5% interest (PIK), conversion price $0.73 (15% premium to close), 10-year maturity.
Series A-1/B-1/C-1 warrants at $0.81/$0.92/$1.10 exercise prices, expiring 10 years (some subject to early expiry based on sales or FDA approval).
Proceeds to repay existing $12M Nov 2023 senior notes and for working capital; first closing Nov 7, second Nov 26, 2025.
CEO Kathy Lee Sepsick, CFO, and board member purchased $100k of notes/warrants on same terms as other investors.
Lead lender Pointillist Global Macro receives board nomination right until ownership <4.99% or 5 years; standstill at 30%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.